Related Experiment Video
Updated: Jan 12, 2026
09:49
Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
Published on: January 20, 2023
3.6K
Developmental Considerations for Pediatric Unintentional Injury Prevention
Maneesha Agarwal1, Terri D McFadden2, David C Schwebel3
1Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, 49 Jesse Hill Jr Drive, Atlanta, GA 30303, USA; Department of Emergency Medicine, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA.
Pediatric Clinics of North America
|November 5, 2025
Summary
Childhood injuries are a major cause of death, with risks changing as children develop. This review covers age-specific injury risks and prevention for all children, including those with developmental differences.
Area of Science:
- Pediatric medicine
- Developmental psychology
- Public health
Background:
- Injuries represent the primary cause of mortality in children and adolescents.
- Injury risks are dynamic and evolve throughout childhood and adolescence due to developmental changes.
- Understanding these developmental shifts is crucial for effective injury prevention.
Purpose of the Study:
- To review injury risk factors and prevention strategies relevant to different stages of child development.
- To provide clinicians with information for counseling families on pediatric injury prevention.
- To address specific injury considerations for children with developmental differences.
Main Methods:
- Literature review of developmental changes impacting injury risk.
- Synthesis of age-specific injury risk factors.
- Identification of tailored prevention strategies.
- Inclusion of considerations for children with autism spectrum disorder, attention-deficit/hyperactivity disorder, and sensory impairments.
Main Results:
- Developmental changes in physical, cognitive, motor, and social domains significantly influence injury susceptibility.
- Prevention strategies must be adapted to the evolving developmental stage of the child.
- Children with developmental differences may face unique or amplified injury risks requiring specialized approaches.
Conclusions:
- Effective pediatric injury prevention necessitates a developmental perspective.
- Clinicians play a vital role in educating families about age-appropriate risks and safety measures.
- Tailored strategies are essential for protecting children with developmental differences from injury.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
201
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
201
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
249
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
239
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
239
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
185
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
185
01:29Drug Dosing: Infants and Children
241
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
241
01:22Healthcare Associated Infections II: Preventive Measures
3.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K